🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
LH
NYSE
🇺🇸 US
Labcorp Holdings Inc.
Healthcare
17Score
DipBuster Score™
$310.29
+$1.09 (+0.35%)
Live price · Source: Yahoo
52-Week Position
$244.52
92% of range
$316.11
Beta
0.861
Market-like
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.861
52W High$316.11
52W Low$244.52
DipBuster Brief
Key signals at a glance
Zone: Consider Trimming
Bearish
Near 52-Week High — Asymmetric Risk
At 92% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position92% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.861
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Labcorp Holdings Inc. (LH), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-07-02 | Vaughn Bryan T | SELL | 234 |
| 2026-07-02 | Kyle Kathryn W | SELL | 92 |
| 2026-07-01 | Vaughn Bryan T | SELL | 327 |
| 2026-07-01 | Vaughn Bryan T | SELL | 93 |
| 2026-07-01 | Vaughn Bryan T | BUY | 327 |
| 2026-07-01 | Kyle Kathryn W | SELL | 256 |
| 2026-07-01 | Kyle Kathryn W | SELL | 73 |
| 2026-07-01 | Kyle Kathryn W | BUY | 256 |
| 2026-06-08 | Kyle Kathryn W | SELL | 762 |
| 2026-05-11 | Schechter Adam H | SELL | 5,903 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.861
Dividend/yrNone
52W High$316.11
52W Low$244.52
52-Week Range
$244.52Now$316.11
92% through annual range
From 52W High−1.8%
From 52W Low+26.9%
📖 Plain English Summary
Labcorp Holdings Inc. is at 92% of its 52-week range. Beta 0.861 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for LH
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — LH
Heuristic · balance sheet, insider filings, price data, academic research
Labcorp Holdings Inc. — DipBuster Score 17/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Labcorp Holdings Inc. free
Add LH to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
3/25
Momentum & Volume
9/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
0
/100 · NEUTRAL
dip depth
0/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 17/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident …
Sector
Healthcare
Market
🇺🇸 US
CEO
Adam H. Schechter
Staff
71,000 employees
Website